Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019.
Schuh AJ, Kyondo J, Graziano J, Balinandi S, Kainulainen MH, Tumusiime A, Nyakarahuka L, Mulei S, Baluku J, Lonergan W, Mayer O, Masereka R, Masereka F, Businge E, Gatare A, Kabyanga L, Muhindo S, Mugabe R, Makumbi I, Kayiwa J, Wetaka MM, Brown V, Ojwang J, Nelson L, Millard M, Nichol ST, Montgomery JM, Taboy CH, Lutwama JJ, Klena JD. Schuh AJ, et al. Among authors: millard m. PLoS Negl Trop Dis. 2021 Dec 3;15(12):e0009967. doi: 10.1371/journal.pntd.0009967. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34860831 Free PMC article.
Epidemiology and Surveillance of Influenza Viruses in Uganda between 2008 and 2014.
Wabwire-Mangen F, Mimbe DE, Erima B, Mworozi EA, Millard M, Kibuuka H, Lukwago L, Bwogi J, Kiconco J, Tugume T, Mulei S, Ikomera C, Tsui S, Malinzi S, Kasasa S, Coldren R, Byarugaba DK. Wabwire-Mangen F, et al. Among authors: millard m. PLoS One. 2016 Oct 18;11(10):e0164861. doi: 10.1371/journal.pone.0164861. eCollection 2016. PLoS One. 2016. PMID: 27755572 Free PMC article.
Pre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in Uganda.
Martins KA, Ayebare RR, Bhadelia N, Kiweewa F, Waitt P, Mimbe D, Okello S, Naluyima P, Brett-Major DM, Lawler JV, Millard M, Walwema R, Cardile AP, Ritchie C, Kwiecien A, Badu H, Espinosa BJ, Beckett C, Bavari S, Zaman S, Christopher G, Clark DV, Lamorde M, Kibuuka H. Martins KA, et al. Among authors: millard m. Health Secur. 2020 Mar/Apr;18(2):114-124. doi: 10.1089/hs.2019.0112. Health Secur. 2020. PMID: 32324070
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.
Paquin-Proulx D, Gunn BM, Alrubayyi A, Clark DV, Creegan M, Kim D, Kibuuka H, Millard M, Wakabi S, Eller LA, Michael NL, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML, Alter G, Eller MA. Paquin-Proulx D, et al. Among authors: millard m. Front Immunol. 2021 May 20;12:682120. doi: 10.3389/fimmu.2021.682120. eCollection 2021. Front Immunol. 2021. PMID: 34093585 Free PMC article.
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, Joshi G, Stanley D, Kunchai M, Eller LA, Bailer RT, Koup RA, Nabel GJ, Mascola JR, Sullivan NJ, Graham BS, Roederer M, Michael NL, Robb ML, Ledgerwood JE; RV 247 Study Team. Kibuuka H, et al. Among authors: millard m. Lancet. 2015 Apr 18;385(9977):1545-54. doi: 10.1016/S0140-6736(14)62385-0. Epub 2014 Dec 23. Lancet. 2015. PMID: 25540891 Clinical Trial.
Prevalence of influenza A viruses in livestock and free-living waterfowl in Uganda.
Kirunda H, Erima B, Tumushabe A, Kiconco J, Tugume T, Mulei S, Mimbe D, Mworozi E, Bwogi J, Luswa L, Kibuuka H, Millard M, Byaruhanga A, Ducatez MF, Krauss S, Webby RJ, Webster RG, Wurapa K, Byarugaba DK, Wabwire-Mangen F. Kirunda H, et al. Among authors: millard m. BMC Vet Res. 2014 Feb 27;10:50. doi: 10.1186/1746-6148-10-50. BMC Vet Res. 2014. PMID: 24576325 Free PMC article.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Happe M, Hofstetter AR, Wang J, Yamshchikov GV, Holman LA, Novik L, Strom L, Kiweewa F, Wakabi S, Millard M, Kelley CF, Kabbani S, Edupuganti S, Beck A, Kaltovich F, Murray T, Tsukerman S, Carr D, Ashman C, Stanley DA, Ploquin A, Bailer RT, Schwartz R, Cham F, Tindikahwa A, Hu Z, Gordon IJ, Rouphael N, Houser KV, Coates EE, Graham BS, Koup RA, Mascola JR, Sullivan NJ, Robb ML, Ake JA, Lyke KE, Mulligan MJ, Ledgerwood JE, Kibuuka H; VRC 208 and RV 422 study team. Happe M, et al. Among authors: millard m. NPJ Vaccines. 2024 Mar 29;9(1):67. doi: 10.1038/s41541-024-00833-z. NPJ Vaccines. 2024. PMID: 38553525 Free PMC article.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML. Kibuuka H, et al. Among authors: millard m. J Infect Dis. 2010 Feb 15;201(4):600-7. doi: 10.1086/650299. J Infect Dis. 2010. PMID: 20078213 Free PMC article. Clinical Trial.
186 results